T1	Participants 137 187	80 patients undergoing biliary or gastric surgery.
T2	Participants 192 200	patients
T3	Participants 437 492	Wound infections developed in two (4.5%) of 44 patients
T4	Participants 520 548	seven (19.4%) of 36 patients
